Early treatment with JNJ-46356479, a mGluR2 modulator, improves behavioral and neuropathological deficits in a postnatal ketamine mouse model of schizophrenia.
暂无分享,去创建一个
E. Parellada | S. Mas | N. Rodríguez | P. Gassó | C. García-Rizo | C. Moren | A. Martínez-Pinteño | L. Prohens | D. Olivares | S. Madero | M. Gómez